Morepen Laboratories Ltd Performance
Day's Low
Day's High
₹73₹76.0152 Week's Low
52 Week's High
₹38.55₹100.9
| Returns % | |
| 1 Month Return | -7.48 % |
| 3 Month Return | + 8.89 % |
| 1 Year Return | + 91.02 % |
| Market Stats | |
| Previous Close | ₹75.93 |
| Open | ₹76.00 |
| Volume | 49.52L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹4,160.61Cr |
Morepen Laboratories Ltd Key Statistics
| P/E Ratio | 30.01 |
| PEG Ratio | 19.88 |
| Market Cap | ₹4,160.61 Cr |
| P/B Ratio | 2.42 |
| EPS | 1.89 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 13.29 |
Morepen Laboratories Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹4,160.61 Cr | 69.59% | 0.53 | ₹96 Cr | ₹1,690 Cr | |
| NA | ₹143.16 Cr | 73.55% | 0.56 | NA | NA | |
| NA | ₹1,388.42 Cr | 84.92% | 0.51 | ₹25 Cr | ₹212 Cr | |
| NA | ₹35.53 Cr | 14.76% | 0.54 | NA | NA | |
| NA | ₹111.21 Cr | 51.29% | 0.55 | NA | NA |
About Morepen Laboratories Ltd
Share Price: ₹73.23 per share as on 21 Nov, 2024 04:01 PM
Market Capitalisation: ₹4,160.61Cr as of today
Revenue: ₹437.73Cr as on September 2024 (Q3 24)
Net Profit: ₹34.85Cr as on September 2024 (Q3 24)
Listing date: 15 May, 1995
Chairperson Name: Sushil Suri
| Organisation | Morepen Laboratories Ltd |
| Headquarters | Gurgaon |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Morepen Laboratories Ltd
Morepen Lab Reports Strong Q2 Performance - 12 Nov, 2024
Morepen Laboratories reported a 0.64% increase in net sales to Rs 383.70 crore for September 2024. Net profit surged 60.25% to Rs 31.93 crore, while EBITDA rose 46.32%. The EPS increased to Rs 0.60. The stock has delivered impressive returns of 76.05% over the last six months and 102.47% over the past year.
Morepen Laboratories Reports Strong Q2 Earnings - 11 Nov, 2024
Morepen Laboratories Limited reported robust earnings for Q2 and six months ended September 30, 2024, with increased sales, revenue, and net income compared to the previous year.
Insights on Morepen Laboratories Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 1 Year
In the last 1 year, MOREPENLAB has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Price Rise
In the last 6 months, MOREPENLAB stock has moved up by 59.5%
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 53.72% to 60.56% in Sep 2024 quarter
NO EFFECTAgainst Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 130.6% return, outperforming this stock by 69.7%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 35.65% of holdings in Sep 2024 quarter
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 7.72% to 2.08% in Sep 2024 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 458.64 Cr → 442.71 Cr (in ₹), with an average decrease of 3.5% per quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 36.17 Cr → 34.85 Cr (in ₹), with an average decrease of 3.7% per quarter
Morepen Laboratories Ltd Financials
Index Inclusions
Morepen Laboratories Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 35.65% | 0.00 | |
| Foreign Institutions | 2.08% | ||
| Mutual Funds | 0% | 157.14 | |
| Retail Investors | 60.56% | 12.74 | |
| Others | 1.71% |
Morepen Laboratories Ltd Key Indicators
Morepen Laboratories Ltd Valuation
Morepen Laboratories Ltd in the last 5 years
Lowest (10.48x)
March 23, 2020
Today (30.01x)
November 19, 2024
Industry (54.42x)
November 19, 2024
Highest (64.70x)
January 22, 2018
Morepen Laboratories Ltd Earnings and Dividends
Morepen Laboratories Ltd Earnings Results
Morepen Laboratories Ltd’s net profit jumped 63.92% since last year same period to ₹34.85Cr in the Q2 2024-2025. On a quarterly growth basis, Morepen Laboratories Ltd has generated -3.65% fall in its net profits since last 3-months.
Read More about Earnings Results
Morepen Laboratories Ltd Technicals Summary
Bearish
Neutral
Bullish
Morepen Laboratories Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Morepen Laboratories Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Morepen Laboratories Ltd shares.
Morepen Laboratories Ltd (MOREPENLAB) share price today is ₹73.23
Morepen Laboratories Ltd is listed on NSE
Morepen Laboratories Ltd is listed on BSE
- Today’s highest price of Morepen Laboratories Ltd is ₹76.01.
- Today’s lowest price of Morepen Laboratories Ltd is ₹73.
PE Ratio of Morepen Laboratories Ltd is 30.01
PE ratio = Morepen Laboratories Ltd Market price per share / Morepen Laboratories Ltd Earnings per share
Today’s traded volume of Morepen Laboratories Ltd(MOREPENLAB) is 49.52L.
Today’s market capitalisation of Morepen Laboratories Ltd(MOREPENLAB) is ₹4160.61Cr.
| Morepen Laboratories Ltd(MOREPENLAB | Price |
|---|---|
52 Week High | ₹100.9 |
52 Week Low | ₹38.55 |
Morepen Laboratories Ltd(MOREPENLAB) share price is ₹73.23. It is down -27.42% from its 52 Week High price of ₹100.9
Morepen Laboratories Ltd(MOREPENLAB) share price is ₹73.23. It is up 89.96% from its 52 Week Low price of ₹38.55
| Morepen Laboratories Ltd(MOREPENLAB | Returns |
|---|---|
1 Day Returns | -2.7% |
1 Month Returns | -7.48% |
3 Month Returns | 8.89% |
1 Year Returns | 91.02% |